fr
en

« Previous 1 2 3 4 5 … 18 Next »

News

BRINGING YOU
THE LATEST

Contacts

September 14, 2022

MedinCell signs a licence agreement with the Medicines Patent Pool to fight malaria transmission, as part of its global health mission

Read press release

September 13, 2022

MedinCell releases the results of its September 8, 2022 ordinary annual and extraordinary general meeting

Read press release

September 5, 2022

MedinCell secures additional 20 million euros financing with the European Investment Bank (EIB)

Read press release

August 29, 2022

Phase 3 study to be initiated for second long-acting injectable antipsychotic using MedinCell’s technology

Read press release

August 17, 2022

An impact company committed to improving the health of patients worldwide, MedinCell publishes its 2021-2022 ESG annual report

Read press release

August 8, 2022

Participation terms in the Combined General Meeting

Read press release

< 1 2 3 4 5 … 18 >

Session en français

Rendez-vous le lundi 14 novembre à 18h00 (CET) pour une vidéoconférence dédiée aux récentes avancées des produits de notre portfeuille clinique

English session

On Monday 14, November at 6.00 pm (CET) participate in our videoconference dedicated to the latest news regarding our clinical and regulatory products

CONTACT